超声引导下射频消融术在甲状腺结节治疗中的应用进展

doi:10.16150/j.1671-2870.2021.02.018

摘要/Abstract

中图分类号:

R736.1

赖丽梅, 周建桥. 超声引导下射频消融术在甲状腺结节治疗中的应用进展[J]. 诊断学理论与实践, 2021, 20(02): 216-220.

参考文献 45

[1]	Haugen BR, Alexander EK, Bible KC, et al. 2015 Ame-rican Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26(1):1-133. doi: 10.1089/thy.2015.0020 URL
[2]	Dupuy DE, Monchik JM, Decrea C, et al. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy[J]. Surgery, 2001, 130(6):971-977. doi: 10.1067/msy.2001.118708 URL
[3]	Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for clinical practice for the diagnosis and management of thyroid nodules- -2016 update[J]. Endocr Pract, 2016, 22(5):622-639.
[4]	Kim JH, Baek JH, Lim HK, et al. 2017 Thyroid radiofrequency ablation guideline: Korean Society of Thyroid Radiology[J]. Korean J Radiol, 2018, 19(4):632-655. doi: 10.3348/kjr.2018.19.4.632 URL
[5]	Papini E, Monpeyssen H, Frasoldati A, et al. 2020 European Thyroid Association Clinical Practice Guideline for the use of image-guided ablation in benign thyroid nodu-les[J]. Eur Thyroid J, 2020, 9(4):172-185. doi: 10.1159/000508484 URL
[6]	中国医师协会甲状腺肿瘤消融治疗技术专家组, 中国抗癌协会甲状腺癌专业委员会, 中国医师协会介入医师分会超声介入专业委员会, 等. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗专家共识(2018版)[J]. 中国肿瘤, 2018, 27(10):768-773.
[7]	中国医师协会超声医师分会. 甲状腺微小乳头状癌热消融诊疗指征专家共识[J]. 中华医学超声杂志(电子版), 2019, 16(8): 571-574.
[8]	Zhou J, Yin L, Wei X, et al. 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodu-les: the C-TIRADS[J]. Endocrine, 2020, 70(2):256-279. doi: 10.1007/s12020-020-02441-y URL
[9]	Ahmed M, Brace CL, Lee FT Jr, et al. Principles of and advances in percutaneous ablation[J]. Radiology, 2011, 258(2):351-369. doi: 10.1148/radiol.10081634 URL
[10]	Park HS, Baek JH, Park AW, et al. Thyroid radiofrequency ablation: updates on innovative devices and techniques[J]. Korean J Radiol, 2017, 18(4):615-623. doi: 10.3348/kjr.2017.18.4.615 pmid: 28670156
[11]	Kim YS, Rhim H, Tae K, et al. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience[J]. Thyroid, 2006, 16(4):361-367. doi: 10.1089/thy.2006.16.361 URL
[12]	Deandrea M, Trimboli P, Garino F, et al. Long-term efficacy of a single session of RFA for benign thyroid nodu-les: a longitudinal 5-year observational study[J]. J Clin Endocrinol Metab, 2019, 104(9):3751-3756. doi: 10.1210/jc.2018-02808 URL
[13]	Jung SL, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study[J]. Korean J Radiol, 2018, 19(1):167-174. doi: 10.3348/kjr.2018.19.1.167 URL
[14]	杜军威, 付利军, 焦赞, 等. 超声引导经皮射频消融治疗甲状腺良性肿瘤疗效分析[J]. 国际外科学杂志, 2019, 46(12):814-818.
[15]	Cheng Z, Che Y, Yu S, et al. US-guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: a prospective multicenter study[J]. Sci Rep, 2017, 7(1):9554. doi: 10.1038/s41598-017-09930-7 URL
[16]	Sung JY, Baek JH, Jung SL, et al. Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study[J]. Thyroid, 2015, 25(1):112-117. doi: 10.1089/thy.2014.0100 URL
[17]	Bernardi S, Stacul F, Michelli A, et al. 12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules[J]. Endocrine, 2017, 57(3):402-408. doi: 10.1007/s12020-016-1174-4 pmid: 27848197
[18]	Noone AHN, Krapcho M, Miller D, et al. SEER Cancer Statictics Review,1975-2015[R]. National Cancer Institute, 2018-10-10[2021-02-08].
[19]	Li M, Brito JP, Vaccarella S. Long-term declines of thyroid cancer mortality: an international age-period-cohort analysis[J]. Thyroid, 2020, 30(6):838-846. doi: 10.1089/thy.2019.0684 URL
[20]	Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid[J]. Thyroid, 2003, 13(4):381-387. doi: 10.1089/105072503321669875 URL
[21]	Lim HK, Cho SJ, Baek JH, et al. US-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: efficacy and safety in a large population[J]. Korean J Radiol, 2019, 20(12):1653-1661. doi: 10.3348/kjr.2019.0192 URL
[22]	Yan L, Lan Y, Xiao J, et al. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients[J]. Thyroid, 2020, 30(12):1745-1751. doi: 10.1089/thy.2020.0106 URL
[23]	Cho SJ, Baek SM, Lim HK, et al. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors[J]. Thyroid, 2020, 30(12):1745-1751. doi: 10.1089/thy.2020.0106 URL
[24]	Xiao J, Zhang M, Zhang Y, et al. Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T_1bN₀M₀ papillary thyroid carcinoma: a retrospective study[J]. Int J Hyperthermia, 2020, 37(1):392-398. doi: 10.1080/02656736.2020.1752945 URL
[25]	Xiao J, Zhang Y, Zhang M, et al. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T_1bN₀M₀ papillary thyroid carcinoma: a comparative study[J]. Clin Endocrinol (Oxf), 2021, 94(4):684-691. doi: 10.1111/cen.14361 URL
[26]	Cao XJ, Liu J, Zhu YL, et al. Efficacy and safety of thermal ablation for solitary T_1bN₀M₀ papillary thyroid carcinoma: a multicenter study[J]. J Clin Endocrinol Metab, 2021, 106(2):e573-e581. doi: 10.1210/clinem/dgaa776 URL
[27]	中国医师协会甲状腺肿瘤消融治疗技术专家组, 中国抗癌协会甲状腺癌专业委员会, 中国医师协会介入医师分会超声介入专业委员会, 等. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗专家共识(2018版)[J]. 中国肿瘤, 2018, 27(10):768-773.
[28]	Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response[J]. World J Surg, 2018, 42(8):2476-2484. doi: 10.1007/s00268-018-4500-6 pmid: 29488064
[29]	Zhao Z, Wu J, Liu X, et al. Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy[J]. Cancer Lett, 2018, 421:73-81. doi: 10.1016/j.canlet.2018.02.024 URL
[30]	Ma B, Wei W, Xu W, et al. Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: a retrospective case review and literature review[J]. Thyroid, 2018, 28(9):1134-1142. doi: 10.1089/thy.2017.0558 URL
[31]	刘新承, 郝少龙, 陈焕杰, 等. 甲状腺乳头状癌热消融治疗后再手术11例分析[J]. 中华普外科手术学杂志(电子版), 2018, 12(4):299-301.
[32]	Lim HK, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer[J]. Eur Radiol, 2015, 25(1):163-170. doi: 10.1007/s00330-014-3405-5 URL
[33]	Choi Y, Jung SL, Bae JS, et al. Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: a single-center propensity score matching study[J]. Int J Hyperthermia, 2019, 36(1):359-367.
[34]	Chung SR, Baek JH, Choi YJ, et al. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer[J]. Eur Radiol, 2019, 29(9):4897-4903. doi: 10.1007/s00330-019-06063-5 pmid: 30805701
[35]	Ha SM, Sung JY, Baek JH, et al. Radiofrequency ablation of small follicular neoplasms: initial clinical outcomes[J]. Int J Hyperthermia, 2017, 33(8):931-937.
[36]	Dobrinja C, Bernardi S, Fabris B, et al. Surgical and pathological changes after radiofrequency ablation of thyroid nodules[J]. Int J Endocrinol, 2015, 2015:576576.
[37]	Biamonte E, Solbiati L, Ierace T, et al. Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation[J]. Endocrine, 2019, 65(3):515-519. doi: 10.1007/s12020-019-01995-w pmid: 31273680
[38]	Miyabayashi C, Ooiwa A, Katakura M, et al. A successful treatment of percutaneous radio frequency ablation for advanced thyroid cancer[J]. Gan To Kagaku Ryoho, 2005, 32(11):1875-1877.
[39]	Jeong SY, Baek JH, Choi YJ, et al. Radiofrequency ablation of primary thyroid carcinoma: efficacy according to the types of thyroid carcinoma[J]. Int J Hyperthermia, 2018, 34(5):611-616. doi: 10.1080/02656736.2018.1427288 URL
[40]	Chung SR, Suh CH, Baek JH, et al. Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis[J]. Int J Hyperthermia, 2017, 33(8):920-930.
[41]	Cho SJ, Baek JH, Chung SR, et al. Long-term results of thermal ablation of benign thyroid nodules: a systematic review and meta-analysis[J]. Endocrinol Metab (Seoul), 2020, 35(2):339-350. doi: 10.3803/EnM.2020.35.2.339 URL
[42]	Trimboli P, Castellana M, Sconfienza LM, et al. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis[J]. Endocrine, 2020, 67(1):35-43. doi: 10.1007/s12020-019-02019-3 URL
[43]	Bernardi S, Giudici F, Cesareo R, et al. Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the italian minimally invasive treatments of the thyroid group[J]. Thyroid, 2020, 30(12):1759-1770. doi: 10.1089/thy.2020.0202 URL
[44]	Hu K, Wu J, Dong Y, et al. Comparison between ultrasound-guided percutaneous radiofrequency and microwave ablation in benign thyroid nodules[J]. J Cancer Res Ther, 2019, 15(7):1535-1540. doi: 10.4103/jcrt.JCRT_322_19 URL
[45]	Choi Y, Jung SL. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis[J]. Thyroid, 2020, 30(5):720-731. doi: 10.1089/thy.2019.0707 URL

超声引导下射频消融术在甲状腺结节治疗中的应用进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 45

相关文章 10

编辑推荐

Metrics

本文评价

[1]	周伟, 陈易来, 詹维伟. 细针穿刺洗脱液中甲状腺球蛋白检测在诊断分化型甲状腺癌淋巴结转移中的应用进展[J]. 诊断学理论与实践, 2020, 19(04): 339-343.
[2]	王星, 汪蓉晖, 张桂萍, 董屹婕, 周伟, 詹维伟. 10 388个甲状腺结节行超声引导下细针抽吸活检的甲状腺癌各亚型诊断准确率的10年研究[J]. 诊断学理论与实践, 2020, 19(04): 359-363.
[3]	顾耀耀, 倪雪君. 超声在甲状腺癌颈部淋巴结转移临床诊断中的实用价值[J]. 诊断学理论与实践, 2019, 18(06): 662-667.
[4]	杨迟晖, 张晶, 孟磊俊, 宫丽平, 常庆, 张泓, 曾乃燕. 对乳头状甲状腺癌临床分子靶标的筛选[J]. 诊断学理论与实践, 2019, 18(04): 402-411.
[5]	冯国伟, 陈刚. ^99mTc-MIBI SPECT/CT甲状旁腺显像发现颈部恶性肿瘤的价值及与超声对比[J]. 诊断学理论与实践, 2018, 17(06): 682-686.
[6]	王晨琛, 詹维伟. 甲状腺癌术后复发转移灶的超声特征及超声引导下细针穿刺的应用价值[J]. 诊断学理论与实践, 2018, 17(01): 111-114.
[7]	杨志芳, 詹维伟,. 超声对桥本甲状腺炎良恶性结节鉴别价值的探讨[J]. 诊断学理论与实践, 2012, 11(02): 176-181.
[8]	冯方,. 甲状腺癌失分化机制的研究进展[J]. 诊断学理论与实践, 2008, 7(04): 460-462.
[9]	顾振辉, 付宏亮, 吴靖川, 王辉, 李佳宁,. 甲状腺癌术后碘-131治疗后腰椎骨密度检测分析[J]. 诊断学理论与实践, 2007, 6(05): 451-452.
[10]	李彪,朱承谟. 核医学在医学诊断中的应用(2)[J]. 诊断学理论与实践, 2003, 2(03): 94-102.